Status:

RECRUITING

Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP)

Lead Sponsor:

Chinese University of Hong Kong

Collaborating Sponsors:

Peking University First Hospital

Hospital Universitario de Torrejón

Conditions:

COVID-19

Eligibility:

FEMALE

18+ years

Brief Summary

The objectives of this proposal are to: 1) determine the rate of SARS-CoV-2 seroconversion in unselected pregnant women in Hong Kong; 2) determine the rate of SARS-CoV-2 infection in women presenting ...

Detailed Description

With over 10 million individuals infected worldwide, the coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global public health cris...

Eligibility Criteria

Inclusion

  • Objective 1: Seroconversion during pregnancy
  • Inclusion criteria:
  • Pregnant women who attended for Down syndrome screening (DSS) at 11-13 weeks
  • Had serum sample taken between 1 November 2019 and 1 June 2020 consented for stored serum for future research
  • Intended to deliver at the booking hospital.
  • Objective 2: SARS-CoV-2 and pregnancy loss
  • Inclusion criteria:
  • •Pregnant women presenting with first and second trimester miscarriage in Hong Kong and Spain, as well as those with stillbirth during periods of 6 and 12 months, respectively.
  • Objective 3: Pregnancy course and perinatal outcome
  • Inclusion criteria:
  • •Pregnant women affected by COVID-19
  • Objective 4: Vertical transmission
  • Inclusion criteria:
  • •Pregnant women affected by COVID-19
  • Objective 5: Potential mechanisms for vertical transmission
  • Inclusion criteria:
  • •Pregnant women affected by COVID-19

Exclusion

    Key Trial Info

    Start Date :

    May 1 2020

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2024

    Estimated Enrollment :

    3000 Patients enrolled

    Trial Details

    Trial ID

    NCT04465474

    Start Date

    May 1 2020

    End Date

    December 31 2024

    Last Update

    February 8 2024

    Active Locations (10)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 3 (10 locations)

    1

    Peking University First Hospital

    Beijing, Beijing Municipality, China

    2

    Kwong Wah Hospital

    Hong Kong, Hong Kong

    3

    Pamela Youde Nethersole Eastern Hospital

    Hong Kong, Hong Kong

    4

    Princess Margaret Hospital

    Hong Kong, Hong Kong